Concepedia
Statistics
Publications
4
Citations
409
H-Index
Active since
2008
Affiliations
Novo Nordisk (Denmark)(Current)
University of Copenhagen
Bo F. Hansen is an author at Novo Nordisk (Denmark) specializing in medicine, cell signaling, and diabetes.
Top concepts
MedicineDiabetesPathologyImmunologyPhysiologyCell BiologyPharmacologyBreast CancerEndocrinologyCell Signaling
Publications per year
2008–2021
A novel high-affinity peptide antagonist to the insulin receptor
Lauge Schäffer, Christian L. Brand, Bo F. Hansen et al. · Biochemical and Biophysical Research Communications · 2008 · 154 citations
Medicine, Diabetes, Insulin Receptor +4
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
Erica Nishimura, Lone Pridal, Tine Glendorf et al. · BMJ Open Diabetes Research & Care · 2021 · 131 citations · Full text
A-769662 activates AMPK β<sub>1</sub>-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle
Jonas T. Treebak, Jesper B. Birk, Bo F. Hansen et al. · American Journal of Physiology-Cell Physiology · 2009 · 108 citations
In Situ Phosphorylation of Akt and ERK1/2 in Rat Mammary Gland, Colon, and Liver Following Treatment with Human Insulin and IGF-1
Henning Hvid, Johannes Josef Fels, Rikke Kaae Kirk et al. · Toxicologic Pathology · 2011 · 16 citations
Immunology, Pathology, Insulin Analog Aspb10 +18
1–4 of 4